The VHL Alliance is running an app design and development contest in order to spread awareness of VHL, as well as to develop a mobile tool that will allow VHL patients, caregivers, and physicians to better manage their care. You can learn more about the contest by going to: vhl.org/appchallenge.
There is no cost to enter and the contest provides a number of benefits, including:
- Worldwide recognition for their hard work and effort on a meaningful project
- Chance to give back by working directly with patients, caregivers, and physicians to make a significant difference in their lives
- Chance to take the material they are learning in the classroom and apply it in real life
- Chance to win $5,000 in prize money
The VHL Alliance (VHLA, vhl.org) is the preeminent resource and clearinghouse of patients, caregivers, researchers, and the medical community, and is connected with approximately 90% of all diagnosed VHL patients throughout the world. VHLA is a 501c3 non-profit organization founded in 1993, which is dedicated to research, education, and support to improve awareness, diagnosis, treatment, and quality of life for those affected by VHL.
VHL, or von Hippel-Lindau disease, is a genetic form of cancer. VHL patients battle a series of tumors, in up to ten organs, throughout their lives. The VHL gene controls the major feeding pipeline of every tumor. Curing VHL is one step closer to curing many other forms of cancer.
The VHL Alliance is a leading funder of VHL research with over $1.8 million granted to support studies designed to find a cure. While these funds have not yet uncovered an effective pharmacological treatment for VHL, the supported research has resulted in approval of multiple cancer drugs for other cancers including kidney and breast cancers.
The deadline to register is Friday, October 6, 2017.